Showing results (761-770 of 1,011) with videos related to
Sort By:
Pageof 102
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.European Journal of Heart Failure|June 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trialMuthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, et al.Journal of the American Heart Association|January 8, 2017
Mean Dietary Salt Intake in Urban and Rural Areas in India: A Population Survey of 1395 PersonsClaire Johnson, Sailesh Mohan, Kris Rogers, et al.Circulation|June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney FunctionBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.BMJ (Clinical Research Ed.)|April 24, 2020
Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling studyMatti Marklund, Gitanjali Singh, Raquel Greer, et al.Journal of Hypertension|June 19, 2025
Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statementJames E Sharman, Aletta E Schutte, Mark R Nelson, et al.Diabetes Care|July 8, 2017
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialToshiaki Ohkuma, Min Jun, Mark Woodward, et al.Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.Cerebrovascular Diseases Extra|December 16, 2019
Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 StudyCandice Delcourt, Cheryl Carcel, Danni Zheng, et al.Diabetologia|September 3, 2016
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetesJoep van der Leeuw, Frank L J Visseren, Mark Woodward, et al.Pageof 102